Diasorin Group

At Diasorin, we are incredibly proud to see our people recognized in Times Square! Congratulations to Alesia Sullivan for being named one of the 2024 Stand Out 50 winners by Future of Field Service! This remarkable achievement reflects Alesia's dedication to living our Diasorin values of innovation, operational excellence, and customer focus every day. By driving innovation and consistently pursuing excellence, our employees continually elevate our services and enhance the experience for our customers. Our people passion and dedication truly bring Diasorin's mission to life!  #obsessedbyscience

💡 "In Diasorin, promuoviamo un ambiente in cui questi valori prendono forma ogni giorno, consentendo ai nostri talenti di crescere e contribuire a creare soluzioni innovative per la salute globale." Queste le parole di Amelia Parente, Senior VP Corporate HR di Diasorin, durante il suo intervento al dibattito promosso dalla Facoltà di Scienze del Farmaco dell'Università degli Studi di Milano nell'ambito della #EuropeanBiotechWeek. Si ringraziano: Prof.ssa Laura Calabresi, Prof. Maurizio Crestani, Prof. Angelo Poletti e i relatori: Paola Pozzi, Claudia Scopelliti, Sara Trifari, Philina Santarelli, PhD, Barbara Rosina #Diasorin #Biotech #Talento #Innovazione

Following the clearance in March 2024 of the LIAISON PLEX® Respiratory Flex Assay, and in June 2024 of the LIAISON PLEX® Yeast Blood Culture Assay, Diasorin today announced it has submitted a 510(k) premarket notification to the FDA for the LIAISON PLEX ® Gram-Negative Blood Culture Assay, the second of the three molecular multiplexing panels for Blood Culture identification on the LIAISON PLEX®. “We firmly believe that LIAISON PLEX® provides unique flexibility by enabling clinicians to select the most appropriate blood panel for their patients. This ensures that clinical laboratories can generate reliable results more quickly and cost-effectively,” said Angelo Rago, President of Luminex. Read more: https://lnkd.in/dRwEu7FZ

The beautiful course of Circolo Golf Torino La Mandria hosted the third edition of the Giovanni Nasi Trophy & Diasorin Cup for Disabled Golfers. The tournament is part of the EDGA international circuit, recognized by the Italian Golf Federation and sponsored by the Italian Paralympic Committee, making it valid for the world ranking. In a year when sports and its values of competition and diversity were celebrated globally at the Olympic and Paralympic Games, nearly 60 athletes from around the world competed in Turin on September 19 and 20, highlighting the role of sports in promoting differences and talents. This important achievement is a recognition of Diasorin's involvement in supporting the event and confirms its role as a key player in fostering the values of sports, diversity, and inclusion. #Diasorin #sport #inclusion #disabledgolfer #edgatour #wr4gd

Diasorin announces the launch of the new LIAISON® 𝑆.𝑝𝑛𝑒𝑢𝑚𝑜𝑛𝑖𝑎𝑒 Antigen Immunodiagnostic Assay, the first immunodiagnostic test on the market allowing high throughput qualitative detection of 𝑆𝑡𝑟𝑒𝑝𝑡𝑜𝑐𝑜𝑐𝑐𝑢𝑠 𝑝𝑛𝑒𝑢𝑚𝑜𝑛𝑖𝑎𝑒 antigen in urine specimens of adult patients with suspected pneumonia, and it provides a precise identification of the pneumococcal pneumonia infection. Read more: https://lnkd.in/g5VsmdRU #DiasorinGroup #Diasorin 

Today, we honor Women's Equality Day, recognizing both the strides made toward gender equality and the journey still ahead. At Diasorin, we support women and we are dedicated to fostering an inclusive workplace where everyone can thrive.  Let's continue to break down barriers and create equal opportunities for all. #DiasorinGroup #Diasorin #WomensEqualityDay

Diasorin raises Full-Year 2024 Guidance as a result of the positive performance of the first semester of the year. Read more: https://lnkd.in/dCXY3P4y

Diasorin confirms its specialty positioning as a molecular diagnostics player, having received the clearance from the FDA on its Simplexa® C. auris Direct assay on the LIAISON® MDX.   The test is the first FDA de-novo granted assay designed to aid in the prevention and control of Candida auris, a rapidly emerging multi drug-resistant fungal pathogen.   “The FDA de-novo authorization for the Simplexa® C. auris Direct kit fills a much-needed gap in C. auris molecular detection and uniquely positions Diasorin as the first molecular diagnostic vendor to commercialize a PCR test for the prevention and control of Candida auris infection in healthcare settings”. Find out more on: https://lnkd.in/dY7-F2eb #Diasorin #DiasorinGroup #pressrelease

Recognizing and enhancing human potential, promoting talent in all its forms, having a positive impact on people’s lives, being an active part of local communities: these values form the basis for our projects in the field of Diversity and Inclusion. Initiatives of great social value involving little patients and lots of talent. Find out more on: https://lnkd.in/dPiT_A29 #Diasorin #DiasorinGroup #ESG #diversity #inclusion

🎉 Celebrating the Conclusion of Mad for Science Challenge 2024! 🎉 The 8th edition of the Mad for Science Challenge, promoted by Fondazione Diasorin, has come to an exciting end! This challenge highlights every year the best young scientific talents in Italy. The competition's goal is to award prizes for the implementation of laboratories at schools, supporting Fondazione Diasorin's mission to spread scientific knowledge starting from high schools. The foundation is dedicated to fostering scientific understanding through various initiatives, and the Mad for Science Challenge is a key activity. Its ultimate aim, through these prizes, is to enhance laboratory facilities in schools. The Liceo Scientifico G. TERRAGNI from Olgiate Comasco won the top prize of €75,000 with their project "PLA: a sustainable future?". Liceo Scientifico L. DA VINCI from Maglie (LE) secured second place and €45,000 for "Proactive S-Healing", while Liceo Scientifico I. NEWTON from Chivasso (TO) took third place with €30,000 for their study on probiotics. Finalist Prizes of €10,000 each were awarded to Liceo Scientifico G. GALILEI – M. VETRONE from Benevento (BN), Liceo Scientifico N. BRAUCCI from Caivano (NA), Liceo Scientifico A. FARNESE from Vetralla (VT), Liceo Scientifico B. VARCHI from Montevarchi (AR), and Liceo Scientifico E. MAJORANA – E. CORNER from Mirano (VE). These exceptional schools represent the pinnacle of innovation and dedication in Italian education. Every participant's effort was invaluable in making this competition a success. Follow the journey with #diasoringroup #fondazionediasorin #madforscience #madforscience2024. Watch the Mad For Science Challenge 2024 on the Fondazione Diasorin YouTube channel! Learn more: https://lnkd.in/g4gX8Sqv #Innovation #STEM #Education #ScienceForFuture #MadForScience2024